AAMC Home   Tomorrow's Doctors Tomorrow's Cures
  Home  Government Affairs   Newsroom   Meetings   Publications Shopping Cart   Site Map    

Washington Highlights: April 1, 2005

CY 2006 Physician Payment Projected to Be -4.3 Percent

The Centers for Medicare and Medicaid Services (CMS) March 31 informed the Medicare Payment Advisory Commission (MedPAC) that the update to the 2006 physician fee schedule is currently projected to be -4.3 percent. A 15 percent growth in expenditures for physician services occurred in 2004. CMS stated "major contributors to the rapid increase in spending appear to be certain diagnostic and therapeutic services, including services particularly important in the treatment of chronic illnesses." Increases included: more frequent and more intensive follow-up visits, more frequent and complex imaging and laboratory tests and minor procedures (such as physical therapy and chemotherapy administration), and increased use of drugs in physicians' offices. Medicare Modernization Act (MMA) provisions, such as the 1.5 percent increase in the 2004 physician fee schedule update and the floor on the geographic price index, also contributed to spending growth. It was noted that Medicare Advantage payments are not included in the physician payment's sustainable growth rate (SGR) calculations, thus the 8.5 percent payment rate increase due to MMA provisions and Medicare Advantage enrollment increases did not contribute to the 2004 spending under the physician fee schedule.

Finally, CMS expressed support of MedPAC's recommendations for the development of measures related to the quality and efficiency of care by individual physicians and groups. CMS intends to continue to work with the physician community in this arena.

Information:
Mary Patton, Senior Research Associate
AAMC Division of Health Care Affairs
mpatton@aamc.org
(202) 862-6297

Denise Dodero, Sr. Director, Health Care Affairs
AAMC Health Care Affairs
ddodero@aamc.org
(202) 828-0493

Conyers Reintroduces Resident Hours Legislation

Representative John Conyers, Jr. (D-Mich.) March 10 reintroduced legislation entitled the "Patient and Physician Safety and Protection Act of 2005" (H.R. 1228) that would make the regulation of resident work hours a Medicare hospital condition of participation.

H.R. 1228 would establish specific limits on work hours, allow residents to file anonymous complaints regarding violations, and impose financial penalties for noncompliance. Specifically, the bill limits postgraduate trainees to 80 hours of work per week and 24 hours of work per shift. They must have at least 10 hours between scheduled shifts, at least one of every 7 days off, and at least one full weekend off per month. Emergency Department residents may work no more than 12 continuous hours within the Department. The bill also limits on-call responsibilities to no more than every third night.

The bill directs the Secretary of Health and Human Services (HHS) to promulgate regulations regarding the supervision of residents and the transfer of patient care responsibilities from resident to resident. The legislation also directs the Secretary to designate an individual within HHS to handle resident complaints. That individual would be authorized to conduct anonymous surveys of residents, conduct on-site investigations, and provide public disclosure of hospitals and programs in violation. The bill requires an annual report to Congress on the compliance of hospitals with such requirements. H.R. 1228 also offers whistleblower protections to individuals who report violations to the Secretary, ACGME or hospital management and subjects hospitals to penalties not to exceed $100,000 for violations in each resident training program in any 6-month period.

During the last Congress, Rep. Conyers and Sen. Jon Corzine (D-N.J.) introduced similar resident hours legislation, but no committee or floor action was taken. The AAMC is opposed to such legislation.

Information:
Lynne Davis Boyle, Assistant Vice President
AAMC Government Relations
ldavisboyle@aamc.org
(202) 828-0526

Hospital Price Disclosure Legislation Introduced

Representatives Dan Lipinksi (D-Ill.) and Bob Inglis (R-S.C.) March 17 introduced legislation that would require hospitals and ambulatory surgery centers to report pricing information on inpatient and outpatient procedures and administered drugs. Under "The Hospital Price Disclosure Act" (H.R. 1362), hospitals and ambulatory surgical centers would be required to report quarterly information electronically to the Secretary of Health and Human Services (HHS) on the 25 most frequently performed inpatient and outpatient procedures as well as the 50 most frequently administered inpatient drugs. Reporting information must include the frequency of the procedures as well as the average and median procedure or drug price charged by the hospital or center.

The HHS Secretary would be required to post the reported information on the Internet and hospitals and centers are required to "prominently" post a notice indicating the availability of such data.

A press release issued by Rep. Lipinski stated, "As employees are spending more of their own money on health care services, they have a right to know how different health care facilities charge for outpatient procedures." Rep. Lipinski stated that such information will help consumers make better purchasing decisions. Rep. Lipinski became concerned about hospital prices after a bicycle accident last year put him in the hospital.

Information:
Lynne Davis Boyle, Assistant Vice President
AAMC Government Relations
ldavisboyle@aamc.org
(202) 828-0526

Department of Commerce Seeks Comments on Deemed Export Controls

The Bureau of Industry and Security of the U.S. Department of Commerce (DOC) has released a long-awaited advance notice of proposed rulemaking
on "deemed export controls" [70 Federal Register 15607]. If implemented, the proposed rules would have wide-ranging and likely profound impacts on many university activities, including biomedical and biological research and training.

Under federal regulations, a technology is a "deemed export" if the technical knowledge is transferred to a foreign national in the United States. The export of technologies considered important to national security or which have "dual use" (civilian/military) applications is extensively controlled by DOC regulations, for example, by restricting who has access to the technology. Current regulations do not greatly affect the use of technologies in fundamental university research where the intent is to publish or otherwise broadly disseminate such knowledge. But the proposed revised regulations would markedly alter the control regime, and require universities more thoroughly to restrict access to controlled technologies (including, for example, some types of genetically engineered microorganisms, as well as commonplace equipment). Universities would also face heightened requirements for managing and reporting on the security of these technologies. By releasing the advance notice, the DOC hopes to incorporate academic and other researchers' comments in the formulation of a final rule.

The Association of American Universities released a summary of university concerns with the report.

Information:
Susan Ehringhaus, Sr. Director & Regulatory Counsel
AAMC Biomedical Health Sciences Research
sehringhaus@aamc.org
(202) 828-0543

Stephen Heinig, Lead Science Policy Analyst
AAMC Biomedical Health Sciences Research
sheinig@aamc.org
(202) 828-0488

New Leadership at NCRR, CSR

National Institutes of Health (NIH) Director Elias Zerhouni, M.D., March 25 announced that Judith Vaitukaitis, M.D., will step down as Director of the National Center on Research Resources (NCRR) and assume the position of Senior Advisor on Scientific Infrastructure and Resources to the NIH Director. Barbara Alving, M.D., Deputy Director of the National Heart, Lung and Blood Institute (NHLBI) will serve as Acting Director of NCRR while a search is conducted for a permanent Director.

Dr. Zerhouni also announced March 21 the appointment of Antonio Scarpa, M.D., Ph.D., as the new Director of the Center for Scientific Review (CSR). Dr. Scarpa is currently the David and Inez Myers professor and chair of the Department of Physiology and Biophysics at Case Western Reserve University, and a former member of the AAMC Council of Academic Societies (CAS) Administrative Board.